Public funding for proton therapy across Canada

Every province and territory in Canada has a program that may pay for medically necessary treatment outside the country when it is not available in Canada. These are called out-of-country funding programs. Proton therapy is one of the treatments they can cover. This page explains how they work in general. The details are different where you live, so the guide for your province or territory is the place to act.

What these programs are

Each province and territory runs its own public health plan. Each plan has a route to fund treatment abroad when a service is medically necessary and cannot be provided in Canada. The names differ: OHIP in Ontario, AHCIP in Alberta, MSP in British Columbia, RAMQ in Quebec, and so on. The idea is the same. If you need care that Canada cannot provide, your plan may pay for it elsewhere, usually at set rates.

What the programs share

Across Canada, the out-of-country programs tend to share a few features. These patterns hold widely, but always confirm the detail in your own province’s guide.

A physician applies, not the patient. In every province and territory we reviewed, the application is made by a physician, usually a specialist involved in your care. You cannot apply for yourself.

Approval must come before you travel. These programs require written approval before treatment. If you travel and are treated first, you are generally responsible for the cost. Do not book treatment before you have written approval.

The service must be unavailable in Canada. The core test is that the treatment is medically necessary and not available in Canada. For proton therapy, this fits, because Canada has no operating proton therapy centre.

Travel, meals, and accommodation are usually not covered by the health plan. Most plans fund the medical treatment, not the trip. Some provinces and territories run separate travel-assistance programs, with their own rules. This varies, so check your province’s guide.

There is a way to ask for a review if you are declined. Most plans have an appeal or review route with its own deadline. Approval on appeal is very rare, however; for example, according to Tribunal Watch Ontario’s review, fewer than one percent of these appeals in Ontario go the applicant’s way. The effort is better spent on a complete first application. Note the deadlines early where they exist.

How the programs differ

The differences are real and they matter. Do not assume a rule from one province applies to another.

• Who may apply. Some plans accept any physician; some require one specialist; Quebec, for example, requires two.
• The forms and where they go. Ontario uses a named form and an online submission. Others ask the specialist to write a letter. Some do not publish a form number at all.
• Whether proton therapy needs a benefit comparison. In some provinces, a proton plan is compared against a standard radiation plan before approval, to show a real advantage. This is documented in Alberta, Quebec, and British Columbia. It is not published for every province.
• How decisions are appealed, and the deadline. The review body and the time limit are different in each place.

Provinces are also converging on a shared clinical framework: in 2021, pan-Canadian consensus recommendations for proton therapy access, developed with the provincial cancer agencies, were distributed to every cancer program in Canada.

Because of these differences, the rules that apply to you are the rules of the province or territory where you live.

Find your province or territory

Go to the province selector

A realistic word on proton therapy and these programs

These programs fund treatment that is unavailable in Canada and medically necessary. For proton therapy, that often means uses with strong evidence, such as certain brain, skull-base, eye, and childhood tumours. For uses where the evidence is debated, such as routine prostate cancer, a plan may consider that appropriate radiation treatment is available in Canada; the outcome depends on your diagnosis. The clinical case your specialist prepares is at the centre of every application.

Frequently asked questions

Sources for this page (3)▸

Each claim on this page is drawn from the individual provincial and territorial guides, where the primary government source is cited. See:

1. Ontario, Alberta, British Columbia, Quebec, Manitoba, Saskatchewan, Nova Scotia, New Brunswick, Newfoundland and Labrador, Prince Edward Island, Yukon, Northwest Territories, Nunavut.
2. Fewer than one percent of these appeals in Ontario are decided for the applicant: Tribunal Watch Ontario, “The Ontario tribunal where claimants have almost no chance of winning,” September 2025. tribunalwatch.ca (checked 2026-07-15)
3. Proton therapy programs in some provinces require a benefit assessment against photon therapy, provinces require expert case review, and in 2021 pan-Canadian consensus recommendations for proton therapy access were distributed to cancer programs: pan-Canadian consensus, Radiotherapy and Oncology, 2021, PubMed 36228758. pubmed.ncbi.nlm.nih.gov (checked 2026-07-06)

---

Every statement on this page is drawn from the sources listed below. Last updated: 15 July 2026.

This page is for general education only. It is not medical advice and it is not a decision about your care or your funding. Only your treating physician can advise you on treatment. Only your provincial or territorial health plan can decide whether it will fund treatment outside the country. protontherapy.ca is an information resource by Maple Med Global (MMG Medical Tourism Inc.), Toronto, Canada. We are not a hospital, a clinic, or a government body, and we do not provide medical care.